Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis

By Vallur A. C.   Duthie M. S.   Reinhart C.   Tutterrow Y.   Hamano S.   Bhaskar K. R. H.   Coler R. N.   Mondal D.   Reed S. G.  

Clinical Microbiology & Infection, Vol. 20, Iss. 6, 2014-06 ,pp. : 374-383

Blackwell Publishing

Access to resources Recommend Favorite

Cellular immune responses to recurring influenza strains have limited boosting ability and limited cross-reactivity to other strains

By Keynan Y.   Card C. M.   Ball B. T.   Li Y.   Plummer F. A.   Fowke K. R.  

Clinical Microbiology & Infection, Vol. 16, Iss. 8, 2010-08 ,pp. : 1179-1186

Blackwell Publishing

Access to resources Recommend Favorite

Leishmaniasis in immunosuppressed individuals

By Griensven J.   Carrillo E.   López-Vélez R.   Lynen L.   Moreno J.  

Clinical Microbiology & Infection, Vol. 20, Iss. 4, 2014-04 ,pp. : 286-299

Blackwell Publishing

Access to resources Recommend Favorite

Leishmaniasis chemotherapy—challenges and opportunities

By Croft S. L.   Olliaro P.  

Clinical Microbiology & Infection, Vol. 17, Iss. 10, 2011-10 ,pp. : 1478-1483

Blackwell Publishing

Access to resources Recommend Favorite

Leishmaniasis impact and treatment access

By den Boer M.   Argaw D.   Jannin J.   Alvar J.  

Clinical Microbiology & Infection, Vol. 17, Iss. 10, 2011-10 ,pp. : 1471-1477

Blackwell Publishing

Access to resources Recommend Favorite